SB 202 (see companion bill HB 279) – Maryland
Status: EnactedYear Introduced: 2023
Link: https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/sb0202?ys=2023RS
Reestablishing the requirement that the Prescription Drug Affordability Board, under certain circumstances, draft a plan of action for implementing a process to set upper payment limits for certain prescription drug products; reestablishing the authority of the Board to set upper payments limits, under certain circumstances, for prescription drug products that are purchased or paid for by or through certain State or local government entities, plans, or programs; etc.
Key Issues:
PHARMACEUTICALS
Drug Pricing
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found